David Mountcastle
Known title: Chief Financial OfficerCIK: 0001858396
Associated companies
Transaction History
| PRVA | ▼ Sell | Open Market | 21,275 | $589K | 7/9/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 600 | $17K | 7/7/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 24,734 | $680K | 7/2/2026 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 17,196 | $34K | 6/26/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 17,196 | $433K | 6/26/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 3,385 | $77K | 5/11/2026 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 1,206 | $2K | 5/4/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 1,206 | $30K | 5/4/2026 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 7,179 | $14K | 5/1/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 7,179 | $180K | 5/1/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 5,566 | $116K | 4/2/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 6,391 | $141K | 3/16/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 6,565 | $141K | 3/13/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 6,453 | $141K | 3/12/2026 | View on chart |
| PRVA | ▲ Buy | Grant | 42,584 | $0 | 3/11/2026 | View on chart |
| PRVA | ▲ Buy | Grant | 35,335 | $0 | 3/10/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 5,829 | $133K | 3/9/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 5,177 | $120K | 3/6/2026 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 7,697 | $15K | 2/27/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 7,697 | $193K | 2/27/2026 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 5,361 | $11K | 2/26/2026 | View on chart |
| PRVA | ▼ Sell | Open Market | 5,361 | $134K | 2/26/2026 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 23,887 | $48K | 12/12/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 23,887 | $598K | 12/12/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 3,322 | $83K | 5/12/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 3,445 | $80K | 4/30/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 5,630 | $126K | 4/2/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 2,872 | $69K | 3/11/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 2,979 | $73K | 3/10/2025 | View on chart |
| PRVA | ▲ Buy | Grant | 33,430 | $0 | 3/5/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 100,000 | $2.5M | 2/14/2025 | View on chart |
| PRVA | ▼ Sell | Open Market | 2,232 | $40K | 5/10/2024 | View on chart |
| PRVA | ▼ Sell | Open Market | 2,320 | $43K | 4/30/2024 | View on chart |
| PRVA | ▼ Sell | Open Market | 3,933 | $70K | 4/2/2024 | View on chart |
| PRVA | ▲ Buy | Grant | 38,058 | $0 | 3/8/2024 | View on chart |
| PRVA | ▲ Buy | Grant | 22,058 | $0 | 5/9/2023 | View on chart |
| PRVA | ▼ Sell | Open Market | 1,740 | $47K | 5/2/2023 | View on chart |
| PRVA | ▼ Sell | Open Market | 1,720 | $47K | 5/1/2023 | View on chart |
| PRVA | ▼ Sell | Open Market | 5,506 | $152K | 4/3/2023 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 55,867 | $112K | 11/21/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 4,167 | $8K | 10/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 3,667 | $131K | 10/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 500 | $18K | 10/5/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 12,862 | $26K | 9/6/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 6,159 | $247K | 9/6/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 63,694 | $127K | 8/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 30,594 | $1.2M | 8/5/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 7,324 | $15K | 7/21/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 7,324 | $266K | 7/21/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 51,756 | $104K | 7/18/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 24,990 | $851K | 7/18/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 25 | $875 | 7/18/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 3,429 | $120K | 7/15/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 3,429 | $7K | 7/15/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 2,492 | $5K | 7/7/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 1,212 | $39K | 7/7/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 20,000 | $40K | 7/6/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 9,723 | $299K | 7/6/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 10 | $311 | 7/6/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 19,280 | $39K | 7/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 17,580 | $538K | 7/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 1,100 | $34K | 7/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 500 | $16K | 7/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 100 | $3K | 7/5/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 32 | $64 | 6/28/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 32 | $960 | 6/28/2022 | View on chart |
| PRVA | ▲ Buy | Grant | 48,833 | $0 | 4/1/2022 | View on chart |
| PRVA | ▲ Buy | Option Exercise | 21,554 | $43K | 1/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 16,391 | $418K | 1/5/2022 | View on chart |
| PRVA | ▼ Sell | Open Market | 25,000 | $626K | 12/22/2021 | View on chart |
| PRVA | ▼ Sell | Open Market | 27,278 | $746K | 11/5/2021 | View on chart |
| PRVA | ▼ Sell | Open Market | 801 | $22K | 11/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Privia Health to Report Q3 2026 Results on Nov 5
Privia Health Group is scheduled to announce its third-quarter 2026 financial results on November 5. Recent coverage highlights the company's role in healthcare automation aimed at reducing administrative costs. With the stock currently trading near its support level, investors will be watching the earnings report for updates on revenue trends and cost management.
Privia Health to Report Q3 2026 Results on Nov 5. Privia Health Group is scheduled to announce its third-quarter 2026 financial results on November 5. Recent coverage highlights the company's role in healthcare automation aimed at reducing administrative costs. With the stock currently trading near its support level, investors will be watching the earnings report for updates on revenue trends and cost management.